Rajeev Mantri is Managing Director at Navam Capital. Rajeev is also Director at GPSK Investment Group, a proprietary trading and investment management firm active in India’s financial markets. Prior to founding Navam Capital, Rajeev worked at New York-based venture capital fund Lux Capital, focusing on investments in energy, water and advanced materials. Rajeev has been a columnist on technology, venture capital and entrepreneurship in India for Mint, The Wall Street Journal, Financial Times,
New York Times, BioSpectrum, The Economic Times, Times of India, MIT Technology Review and other leading publications. Rajeev is also Co-Founder of biopharma venture Vyome Therapeutics, and served as Vyome's president through the company's formative years.
Rajeev graduated with a bachelor of science degree in materials science and engineering from Northwestern University and an MBA from Columbia Business School. He has been recognized as a Raisina Fellow by Observer Research Foundation, and attended King's College London as Chevening Fellow in Financial Services.
Dr Carl Barrelet is a Venture Partner with Navam Capital, focusing on investments in the energy, advanced materials, and life sciences sectors. He has been investing in emerging technologies since 2007. Carl started as a venture capitalist at Lux Capital in New York where he worked on investments in energy, advanced materials, and water technologies. At Lux Capital, Carl led the investment diligence that was instrumental to the founding of Kurion, an energy solutions venture that has emerged as a leader in its field. Prior to joining Navam Capital, Carl was a fund manager with Pictet Asset Management, making public market investments in the global energy and water industry.
Carl graduated with a B.S in Physics from Stanford University, where he received the Dean’s Award for Academic Accomplishment. He then completed a PhD in chemical physics at Harvard University, where he was a Karplus Fellow. During graduate studies, Carl also spent a year at École Normale Supérieure in Paris working under Physics Nobel Laureate Claude Cohen-Tannoudji. Carl has authored 17 peer-reviewed scientific publications and has made several inventions in nanoelectronics, such as novel nanowire photonic circuit elements.
Dr Shiladitya Sengupta is a Venture Partner with Navam Capital. He is Assistant Professor at Harvard Medical School and is also member of the steering committee at the Regenerative Medicine Center at the Brigham and Women's Hospital in Boston, United States. Shiladitya has a long track record as a successful life sciences entrepreneur, and is the Co-Founder of Cerulean Pharmaceuticals, Mitra Biotech, Vyome Biosciences and Invictus Oncology. Shiladitya's academic research focuses on the development of novel nanomedicine for cancer and angiogenesis-based diseases. In 2005, he was recognized as one of the top 35 innovators worldwide by MIT Technology Review magazine.
He has also received the Era of Hope Scholar Award and the Innovator Collaborative Award from the US Department of Defense, the Coulter Foundation Career Award and the Shakuntala Amir Chand Award from the Indian Council for Medical Research. Shiladitya is an alumnus of the All India Institute of Medical Sciences, where he received the Geeta Mital Gold Medal, and completed his PhD as a Nehru Scholar from Trinity College at Cambridge University in UK, following which he was a Fellow at MIT before joining Harvard Medical School. Shiladitya has published over 35 peer-reviewed scientific papers, including in Nature and Proceedings of the National Academy of Sciences, and he is also listed as an inventor on several pending patents.
Alan Rosling is Senior Advisor and Operating Partner at Navam Capital. A seasoned executive who has run businesses in a number of industries, he brings a wealth of strategic and operational experience to Navam’s investment team.
Alan is Co-Founder of Kiran Energy, one of India’s leading solar power companies backed by a consortium of private equity funds. Kiran Energy has over 90 MW of solar power capacity operating in Gujarat and Rajasthan and is implementing new projects in Maharashtra, Karnataka and Tamil Nadu.
Prior to co-founding Kiran, Alan was Executive Director of Tata Sons Limited from 2004-2009, where he was responsible for internationalising the Tata Group. From 1998 to 2003, he was chairman of the Jardine Matheson Group in India.
He also chairs Griffin Growth Partners, a consulting firm advising international companies on their India and emerging markets business strategy. Alan is a non-executive director of UK-based Coats plc, a $1.6 billion textiles company, and NASDAQ-listed Constellation Alpha Capital Corp.
Earlier in his career, Alan served as Special Advisor to British Prime Minister John Major at No. 10 Downing Street’s Policy Unit and also worked in investment banking at S.G. Warburg & Co. in London.
Alan read history at Downing College, Cambridge University and graduated with an MBA from Harvard Business School as Baker Scholar. He was awarded the Order of the British Empire (OBE) in 1994 and the Commander of the Order of the British Empire (CBE) in 2014.